Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model
Sanne Van Campenhout, Laurentijn Tilleman, Sander Lefere, Astrid Vandierendonck, Sarah Raevens, Xavier Verhelst, Anja Geerts, Filip Van Nieuwerburgh, Hans Van Vlierberghe, Lindsey Devisscher
Topics & Concepts
SteatohepatitisMyeloidEndocrinologyInternal medicinePopulationFatty liverMacrophageMedicineBiologyImmunologyIn vitroDiseaseEnvironmental healthBiochemistryImmune cells in cancerFerroptosis and cancer prognosisLiver Disease Diagnosis and Treatment